Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Neoplasms
×
Immunotherapy
×
Clear all
Filters
3
NCT05063565
2026-03-02
ROWAN
Boston Scientific Corporation
Phase 2
Active not recruiting
100 enrolled
NCT02609386
2024-01-30
INSPIRE
Brooklyn ImmunoTherapeutics, LLC
Phase 2
Completed
105 enrolled
17 charts